Medipekt

Bromhexine Hydrochloride, the active ingredient in Medipekt, is a mucolytic presented as an oral tablet for oral use. It helps to loosen and clear thick bronchial mucus in patients with acute or chronic respiratory conditions.

GNH USA supplies Medipekt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medipekt, a mucolytic, is indicated for disorders of the respiratory tract where mucus clearance is impaired.

- Acute bronchitis: reduces mucus viscosity to ease productive cough. - Chronic bronchitis: facilitates expectoration and improves airway patency. - Chronic obstructive pulmonary disease (COPD): aids clearance of bronchial secretions during exacerbations. - Productive cough associated with respiratory tract infections: promotes sputum removal and symptom relief.

Bromhexine Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset occurring after oral intake. - Vomiting: occasional expulsion of stomach contents. - Abdominal discomfort: transient pain or cramping. - Diarrhoea: loose stools that resolve with continued therapy. - Taste disturbances: altered or metallic taste. - Skin rash: mild erythematous eruption.

Serious or Rare Side Effects: - Allergic reactions: including angioedema or anaphylaxis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatotoxicity: abnormal liver function tests. - Blood dyscrasias: rare cases of neutropenia or eosinophilia. - Bronchospasm: paradoxical tightening of airways. - Persistent vomiting: may lead to dehydration.

When using Medipekt, consider the following precautions to ensure safe and effective therapy.

- Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown safety; weigh benefits against potential risks. - Renal impairment: monitor renal function as the drug is excreted renally. - Asthma: may provoke bronchospasm; observe respiratory status. - Duplicate mucolytic therapy: avoid concomitant use of other expectorants. - Store at below 25°C: keep in the original pack, protect from moisture.

Bromhexine Hydrochloride can interact with other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticholinergic agents: may reduce mucolytic effect. - Codeine‑containing cough suppressants: counteract expectorant action. - Strong anticholinergic bronchodilators: potential reduction in therapeutic benefit.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics: may increase gastrointestinal irritation. - Antihistamines: possible enhancement of sedation. - Alcohol: can exacerbate gastrointestinal side effects.